Helping Patients Navigate Affordability Challenges


Want to See Us in Action?

Request a demo to see how CareMetx helps patients avoid affordability roadblocks.

Request Demo

It is common for affordability barriers to present obstacles for patients trying to get started on therapies. This is often a key decision driver on whether the patient makes a decision to start on a therapy.

This is why we believe that the integration of processes to achieve patient affordability is a key component of the overall patient journey. With CareMetx’s expertise in helping both providers and patients navigate these areas, we will remove this critical barrier to care. 

That means your patients are much less likely to hit roadblocks.  
  • Integrate your Medicare eBV and Low-Income Subsidy transactions with Patient Assistance Programs processing in order to determine whether a patient is already enrolled into a Low-Income Subsidy tier. This capability allows you to identify alternative sources of funding which a patient may qualify for before enrolling the patient into Patient Assistance Programs. 
  • Streamline your Copay and Patient Assistance Programs enrollment, qualification and triage processes.
  •  Reduce dependencies on financial documentation through our income validation partnership with a leading national financial clearinghouse. 
Affordability Enablers

Copay workflows and patient enrollment

Patient Assistance Programs assessment
 
Patient Assistance Program

Latest Insights

2 min read
Is Your Patient Services Program Overlooking the Foundation of Successful Treatment?

Delving into the patient journey reveals that adhering to a therapy regimen is a significant hurdle for many people....

3 min read
Enhancing Patient Services: The Crucial Role of Provider Satisfaction

Leading manufacturers recognize that to ensure an optimal patient experience, you need to improve the experience for...

3 min read
Survey Data Confirms Manufacturer Priorities for 2024

Each year, the Patient Services Survey gathers insights from pharmaceutical decision-makers, healthcare providers...